SPRY2
Protein sprouty homolog 2
Also known as: hSPRY2, SPY2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O43597
- Gene
- SPRY2
- Ensembl
- ENSG00000136158
- Chromosome
- 13
- Canonical length
- 315 aa
- Protein class
- Disease related genes, Plasma proteins, Predicted membrane proteins
- Subcellular location
- Actin filaments,Microtubules
OverviewNCBI Gene
This gene encodes a protein belonging to the sprouty family. The encoded protein contains a carboxyl-terminal cysteine-rich domain essential for the inhibitory activity on receptor tyrosine kinase signaling proteins and is required for growth factor stimulated translocation of the protein to membrane ruffles. In primary dermal endothelial cells this gene is transiently upregulated in response to fibroblast growth factor two. This protein is indirectly involved in the non-cell autonomous inhibitory effect on fibroblast growth factor two signaling. The protein interacts with Cas-Br-M (murine) ectropic retroviral transforming sequence, and can function as a bimodal regulator of epidermal growth factor receptor/mitogen-activated protein kinase signaling. This protein may play a role in alveoli branching during lung development as shown by a similar mouse protein. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
315 residues, UniProt reviewed canonical sequence.
>O43597|SPRY2
1 MEARAQSGNG SQPLLQTPRD GGRQRGEPDP RDALTQQVHV LSLDQIRAIR NTNEYTEGPT
61 VVPRPGLKPA PRPSTQHKHE RLHGLPEHRQ PPRLQHSQVH SSARAPLSRS ISTVSSGSRS
121 STRTSTSSSS SEQRLLGSSF SSGPVADGII RVQPKSELKP GELKPLSKED LGLHAYRCED
181 CGKCKCKECT YPRPLPSDWI CDKQCLCSAQ NVIDYGTCVC CVKGLFYHCS NDDEDNCADN
241 PCSCSQSHCC TRWSAMGVMS LFLPCLWCYL PAKGCLKLCQ GCYDRVNRPG CRCKNSNTVC
301 CKVPTVPPRN FEKPTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SPRY2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.58
- Highest tissue expression
- 64 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 64 nTPM
- adipose tissue: 62 nTPM
- breast: 59 nTPM
- heart muscle: 46 nTPM
- blood vessel: 40 nTPM
- tongue: 39 nTPM
Single-cell type
- bergmann glia: 134 nCPM
- epididymal basal cells: 103 nCPM
- müller glia: 99 nCPM
- schwann cells: 87 nCPM
- fibro-adipogenic progenitors: 79 nCPM
- astrocytes: 79 nCPM
Immune cell
- NK-cell: 4.1 nTPM
- eosinophil: 2.1 nTPM
- myeloid DC: 0.9 nTPM
- memory CD8 T-cell: 0.8 nTPM
- memory B-cell: 0.4 nTPM
- gdT-cell: 0.3 nTPM
Brain region
- cerebellum: 78 nTPM
- medulla oblongata: 64 nTPM
- white matter: 48 nTPM
- cerebral cortex: 47 nTPM
- spinal cord: 47 nTPM
- midbrain: 42 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SPRY2.
Disease | AllUniProt
Conditions SPRY2 is implicated in, by any mechanism.
- IgA nephropathy 3 (IGAN3) MIM:616818
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.27
- gnomAD pLI
- 0.97
- gnomAD missense Z
- 0.97
- DepMap mean gene effect
- 0.11
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- animal organ development
- bud elongation involved in lung branching
- cell fate commitment
- cellular response to leukemia inhibitory factor
- cellular response to vascular endothelial growth factor stimulus
- ERK1 and ERK2 cascade
- establishment of mitotic spindle orientation
- fibroblast growth factor receptor signaling pathway
- inner ear morphogenesis
- lung growth
- negative regulation of angiogenesis
- negative regulation of apoptotic process
- negative regulation of cell population proliferation
- negative regulation of cell projection organization
- negative regulation of epidermal growth factor receptor signaling pathway
- negative regulation of epithelial to mesenchymal transition
- negative regulation of ERK1 and ERK2 cascade
- negative regulation of fibroblast growth factor receptor signaling pathway
- negative regulation of lens fiber cell differentiation
- negative regulation of neurotrophin TRK receptor signaling pathway
- negative regulation of protein ubiquitination
- negative regulation of Ras protein signal transduction
- negative regulation of transforming growth factor beta receptor signaling pathway
- negative regulation of vascular endothelial growth factor signaling pathway
- positive regulation of cell migration
- positive regulation of epidermal growth factor receptor signaling pathway
- positive regulation of ERK1 and ERK2 cascade
- positive regulation of gene expression
- positive regulation of peptidyl-serine phosphorylation
- positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- sensory perception of sound
Molecular functions
- protein kinase binding
- protein serine/threonine kinase activator activity
- protein serine/threonine kinase inhibitor activity
- ubiquitin-protein transferase inhibitor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SPRY2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SPRY2 as an antibody target. Whether an autoantibody or antibody against SPRY2 could matter depends on whether native SPRY2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SPRY2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SPRY2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...